Shubham Atal

6PUBLICATIONS
9CO-AUTHORS
Environmental epidemiologyClinical pharmacology and therapeuticsMolecular medicinePharmacogenomicsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 17, 2023
Genetic predisposition for the development of lamotrigine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis.

Sayan Kumar Das, Ananyan Sampath, Sameer Uz Zaman

|Mar 23, 2023
Use of baricitinib in treatment of COVID-19: a systematic review.

Ananyan Sampath, Aditya Banerjee, Shubham Atal

|Jun 21, 2021
Remogliflozin: the new low cost SGLT-2 inhibitor for type 2 diabetes mellitus.

Shubham Atal, Zeenat Fatima, Sakshi Singh

|Jul 21, 2020
Development and validation of a mathematical model to quantify antibiotic consumption in paediatric population: A hospital-based pilot study.

Balakrishnan Sadasivam, Shikha Malik, Shubham Atal

|Jun 15, 2020
IL-6 Inhibitors in the Treatment of Serious COVID-19: A Promising Therapy?

Shubham Atal, Zeenat Fatima

|Feb 01, 2020
Assessment of the understanding of informed consent including participants' experiences, and generation of a supplemental consent decision aid for Gestational Diabetes Mellitus (GDM) research.

Shubham Atal, Fidelma Dunne

Pageof 1

Frequent Collaborators

2 joint publications

Ananyan Sampath

1 joint publications

Balakrishnan Sadasivam

1 joint publications

Shikha Malik

1 joint publications

Shah Newaz Ahmed